Charles River Laboratories holds an official ranking among major corporate lists, having secured its position as a constituent of the S&P 500 index following years of consistent multi-billion-dollar revenue expansion. While corporate inclusion benchmarks shift dynamically based on annual revenue thresholds and market capitalization rankings across the American corporate landscape, the enterprise maintains its status as a major multi-billion-dollar S&P 500 healthcare and life sciences corporation.